Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Food effect, tolerability and pharmacokinetics of ACT-709478 in healthy volunteers: A single-ascending dose study.

Trial Profile

Food effect, tolerability and pharmacokinetics of ACT-709478 in healthy volunteers: A single-ascending dose study.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 20 Apr 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs ACT 709478 (Primary)
  • Indications Epilepsy
  • Focus Adverse reactions; First in man; Pharmacokinetics
  • Most Recent Events

    • 20 Apr 2019 Results investigating the pharmacokinetics, pharmacodynamics, tolerability, and safety of single doses of ACT-709478 in healthy subjects, published in the Epilepsia.
    • 28 Mar 2018 New trial record
    • 24 Mar 2018 Results presented at the 119th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top